Shares in AcelRx Pharmaceuticals (NSDQ:ACRX) rose today after the pharmaceutical company met expectations on Wall Street with its 4th quarter results.
The Redwood City, Calif.-based company pared its losses to -$9.7 million, or -21¢ per share, on sales of $6.4 million for the 3 months ended Dec. 31, for bottom-line growth of 8.2% on sales growth of 276.5% compared with the same period last year.
Adjusted to exclude 1-time items, losses per share were -21¢, ahead of the -24¢ consensus on The Street.
Get the full story at our sister site, Drug Delivery Business News.
The post AcelRx Pharmaceuticals gains on Q4 earnings appeared first on MassDevice.
from MassDevice http://ift.tt/2mVqGSg
Cap comentari:
Publica un comentari a l'entrada